From: Susceptible gene polymorphism in patients with three-vessel coronary artery disease
Gene | SNP | Allele model | OR (95%CI) | P-value |
---|---|---|---|---|
CDKN2B-AS1 | rs1063192 A > G | DO AA/GG + GA | 0.85 (0.45, 1.60) | 0.613 |
RE GG/GA + AA | 0.25 (0.06, 1.00) | 0.05 | ||
rs10757274 A > G | DO AA/GG + GA | 0.99 (0.45, 2.05) | 0.977 | |
RE GG/GA + AA | 0.86 (0.42, 1.74) | 0.67 | ||
rs1333042 G > A | DO GG/AA+GA | 1.00 (0.53, 1.86) | 0.99 | |
RE AA/GA + GG | 2.14 (0.79, 5.83) | 0.137 | ||
rs1333049 G > C | DO GG/CC + GC | 1.43 (0.69, 2.98) | 0.338 | |
RE CC/GC + GG | 1.21 (0.60, 2.43) | 0.593 | ||
rs3217986 T > G | DO TT/GG + GT | 1.29 (0.53, 3.14) | 0.572 | |
RE GG/GT + TT |  |  | ||
rs4977574 A > G | DO AA/GG + GA | 1.00 (0.48, 2.06) | 0.989 | |
RE GG/GA + AA | 0.86 (0.42, 1.74) | 0.67 | ||
rs9632884 C > G | DO CC/GG + GC | 0.95 (0.51, 1.78) | 0.872 | |
RE GG/GC + CC | 0.24 (0.09, 0.65) | 0.005 | ||
ADAMTS13 | rs1055432 C > A | DO CC/AA+AC | 1.43 (0.72, 2.86) | 0.307 |
RE AA/AC + CC | 1.34 (0.03, 64.99) | 0.882 | ||
ABO | rs8176694 T > C | DO TT/CC + CT | 0.28 (0.07, 1.14) | 0.075 |
RE CC/CT + TT | 0.70 (0.09, 5.53) | 0.733 |